Year: 2025
Type: article
Study design: Case Report
Abstract: Enterocutaneous fistula (ECF) formation is a rare but severe complication of bevacizumab therapy. This case report documents the first known patient to develop both an ECF and a colovaginal fistula following bevacizumab treatment for recurrent cervical cancer without prior radiation therapy. A comprehensive literature review of current and nutritional management guidelines, in the context of this patient's complex condition, highlights the need for refined risk stratification and management frameworks. This report aims to contribute to the evolving understanding of bevacizumab's adverse effects and inform future therapeutic decision-making.
Source: Cureus
DOI: 10.7759/cureus.92925
Authors: Madison L Wallace, Linda Akbarshahi, Matthew Bond, Tembele Yangandawele, Thomas Howdieshell
Institutions: Augusta University, Northeast Georgia Medical Center
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4414407138